The Global Digital Biomarkers Market is Driven by Growth in Remote Patient Monitoring
The digital biomarkers market offers products like smartphone apps, wearable devices and other digital platforms that help capture and analyze medical and physiological data such as physical activity, sleep and cognitive responses that act as a substitute for the conventional lab tests to measure disease symptoms or progression. These digital solutions help improve disease diagnosis, predict health outcomes and personalize treatment with real-time insights on the health condition and minimize hospital visits. The integration of digital technologies has enabled new methods of disease management and enabled self-monitoring of health allowing patients to remain mobile and active.
The Global Digital Biomarkers Market is estimated to be valued at US$ 3.3 Bn in 2024 and is expected to exhibit a CAGR of 8.0% over the forecast period 2024 To 2031.
Key Takeaways
Key players operating in the digital biomarkers market are Purina Mills LLC, Nutreco N.V., Roquette Freres S.A., Evonik Industries A G, Charoen Pokphand Foods PLC, Alltech Inc., Associated British Foods Plc., Koninklijke DSM NV, BASF SE, ACI Godrej Agrovet Private Limited. These players are focusing on developing smartphone apps and wearable medical devices that help physicians track a range of health parameters.
The demand for Digital Biomarkers Market Size is growing significantly owing to the rising incidence of chronic diseases worldwide. Remote patient monitoring allows continuous tracking of vitals and symptoms outside of traditional hospital settings improving disease management.
The global digital biomarkers market is also witnessing strong growth due to increasing investments by players for expansion into international markets. Market players are focusing on partnerships with local digital health companies and healthcare providers to strengthen their foreign presence.
Market Drivers
One of the key drivers for the digital biomarkers market is the growth in remote patient monitoring. Digital biomarkers solutions help enable virtual care models and minimize hospital visits through continuous tracking of health metrics at home. This is driving greater adoption across healthcare systems aiming to reduce costs through early detection of disease symptoms and managing patient care virtually particularly post-pandemic. The remote monitoring capabilities allow physicians to closely monitor high-risk patients managing long-term chronic conditions more effectively.
Get more insights on Digital Biomarkers Market
English
Arabic
Français
Español
Português
Türkçe
Dutch
Italiano
Russian
Romaian